Activable Multi-Modal Nanoprobes for Imaging Diagnosis and Therapy of Tumors

Yan Yang1, Saisai Yue1, Yuanyuan Qiao1

  • 1College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.

Frontiers in Chemistry
|April 29, 2021
PubMed

Insights

Smart nanomedicine offers new ways to detect tiny tumors and predict treatment success by imaging the tumor microenvironment. These advanced probes help visualize and target cancer, improving diagnosis and therapy.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Oncology

Background:

  • Malignant tumors are a leading cause of death globally.
  • Effective methods for early tumor diagnosis, metastasis prediction, and treatment efficacy are limited.
  • Understanding the tumor microenvironment (TME) is crucial for cancer progression and therapeutic response.

Purpose of the Study:

  • To review recent advancements in "smart" nanomedicine designed to respond to TME features.
  • To highlight state-of-the-art technologies for tumor imaging, diagnosis, and therapy.
  • To explore the potential of molecular imaging combined with activatable probes for non-invasive TME visualization.

Main Methods:

  • Focus on nanoparticle-based activatable probes.
  • Integration of molecular imaging technologies.
  • Development of nanomedicine responsive to TME parameters like hypoxia and acidic pH.

Main Results:

  • Nanoparticle probes can visualize TME parameters non-invasively.
  • Smart nanomedicine shows promise in accurate tumor diagnosis and treatment.
  • Molecular imaging facilitates understanding of tumor proliferation, invasion, metastasis, and drug resistance.

Conclusions:

  • "Smart" nanomedicine offers a feasible approach for advanced cancer diagnosis and therapy.
  • Targeting TME-specific features with nanoprobes enhances imaging and treatment efficacy.
  • This review consolidates progress in nanomedicine for improved oncology outcomes.

Related Concept Videos